Company intelligence / Profile preview

Ko Da Pharmaceutical

Pingzhen District, Taoyuan, Taiwan

Ownership: Private
Development stage: Other

Overview

Ko Da has over 700 TCM licenses approved by the Taiwan FDA, with products supplied to over 80% of Taiwan's major hospitals and distributed in 15 countries, recognized for their quality control and innovative traceability systems.

Therapeutic areas: ImmunologyInfectious DiseasesOther
Modalities: Herbal medicineSmall molecule
Industry: Food & Nutrition

Beyond the preview

Go deeper on Ko Da Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ko Da Pharmaceutical.

Explore the full profile